JPY 2163.0
(-0.32%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 5.87 Billion JPY | 12.43% |
2022 | 4.79 Billion JPY | 14.37% |
2021 | 4.11 Billion JPY | 30.9% |
2020 | 3.25 Billion JPY | 17.3% |
2019 | 3.18 Billion JPY | 14.06% |
2018 | 2.7 Billion JPY | 2.39% |
2017 | 2.47 Billion JPY | 21.9% |
2016 | 2.32 Billion JPY | -15.48% |
2015 | 2.63 Billion JPY | 30.14% |
2014 | 1.94 Billion JPY | 15.7% |
2013 | 1.64 Billion JPY | 14.57% |
2012 | 1.03 Billion JPY | -15.05% |
2011 | 1.68 Billion JPY | 14.29% |
2010 | 1.48 Billion JPY | -13.07% |
2009 | 1.57 Billion JPY | -13.76% |
2008 | 2 Billion JPY | -1.25% |
2007 | 1.96 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 1.84 Billion JPY | 40.58% |
2023 Q3 | 1.3 Billion JPY | 27.36% |
2023 FY | - JPY | 12.43% |
2023 Q4 | 1.63 Billion JPY | 25.31% |
2023 Q2 | 1.02 Billion JPY | -25.2% |
2023 Q1 | 1.37 Billion JPY | 135.51% |
2022 FY | - JPY | 14.37% |
2022 Q4 | 583 Million JPY | -37.04% |
2022 Q1 | 1.62 Billion JPY | 317.44% |
2022 Q3 | 926 Million JPY | -17.32% |
2022 Q2 | 1.12 Billion JPY | -31.2% |
2021 Q2 | 1.12 Billion JPY | 11.82% |
2021 FY | - JPY | 30.9% |
2021 Q4 | 390 Million JPY | -66.0% |
2021 Q1 | 1 Billion JPY | 36.08% |
2021 Q3 | 1.14 Billion JPY | 1.87% |
2020 Q4 | 740 Million JPY | -7.5% |
2020 FY | - JPY | 17.3% |
2020 Q1 | 81 Million JPY | 112.96% |
2020 Q2 | 815 Million JPY | 906.17% |
2020 Q3 | 800 Million JPY | -1.84% |
2019 FY | - JPY | 14.06% |
2019 Q1 | 500 Million JPY | 13.38% |
2019 Q2 | 745 Million JPY | 49.0% |
2019 Q3 | 575 Million JPY | -22.82% |
2019 Q4 | -625 Million JPY | -208.7% |
2018 Q3 | 490 Million JPY | 32.43% |
2018 FY | - JPY | 2.39% |
2018 Q1 | 416 Million JPY | 43.94% |
2018 Q4 | 441 Million JPY | -10.0% |
2018 Q2 | 370 Million JPY | -11.06% |
2017 Q4 | 289 Million JPY | -32.63% |
2017 Q3 | 429 Million JPY | 1.66% |
2017 Q2 | 422 Million JPY | -2.99% |
2017 FY | - JPY | 21.9% |
2017 Q1 | 435 Million JPY | 57.04% |
2016 FY | - JPY | -15.48% |
2016 Q3 | 362 Million JPY | 85.64% |
2016 Q2 | 195 Million JPY | -38.87% |
2016 Q1 | 319 Million JPY | 16.0% |
2016 Q4 | 277 Million JPY | -23.48% |
2015 Q3 | 302 Million JPY | 19.84% |
2015 FY | - JPY | 30.14% |
2015 Q1 | 592 Million JPY | 545.11% |
2015 Q4 | 275 Million JPY | -8.94% |
2015 Q2 | 252 Million JPY | -57.43% |
2014 Q3 | 220 Million JPY | -56.78% |
2014 Q2 | 509 Million JPY | 30.51% |
2014 FY | - JPY | 15.7% |
2014 Q1 | 390 Million JPY | 117.88% |
2014 Q4 | -133 Million JPY | -160.45% |
2013 Q2 | 347 Million JPY | 388.73% |
2013 Q3 | 390 Million JPY | 12.39% |
2013 FY | - JPY | 14.57% |
2013 Q1 | 71 Million JPY | -85.51% |
2013 Q4 | 179 Million JPY | -54.1% |
2012 FY | - JPY | -15.05% |
2012 Q3 | 173 Million JPY | 652.17% |
2012 Q1 | 81 Million JPY | -78.51% |
2012 Q2 | 23 Million JPY | -71.6% |
2012 Q4 | 490 Million JPY | 183.24% |
2011 Q4 | 377 Million JPY | 97.38% |
2011 Q1 | 153 Million JPY | -60.36% |
2011 FY | - JPY | 14.29% |
2011 Q2 | 255 Million JPY | 66.67% |
2011 Q3 | 191 Million JPY | -25.1% |
2010 FY | - JPY | -13.07% |
2010 Q4 | 386 Million JPY | 38.35% |
2010 Q1 | 447 Million JPY | -10.24% |
2010 Q3 | 279 Million JPY | -20.96% |
2010 Q2 | 353 Million JPY | -21.03% |
2009 Q3 | 350 Million JPY | -5.41% |
2009 Q1 | 473 Million JPY | 5.11% |
2009 Q2 | 370 Million JPY | -21.78% |
2009 Q4 | 498 Million JPY | 42.29% |
2009 FY | - JPY | -13.76% |
2008 FY | - JPY | -1.25% |
2008 Q4 | 450 Million JPY | 34.33% |
2008 Q3 | 335 Million JPY | -18.69% |
2008 Q2 | 412 Million JPY | 0.0% |
2007 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
JINS HOLDINGS Inc. | 10.26 Billion JPY | 42.71% |
Medius Holdings Co., Ltd. | 3.86 Billion JPY | -52.163% |
Ship Healthcare Holdings, Inc. | 31.88 Billion JPY | 81.563% |
JTEC Corporation | 437.18 Million JPY | -1244.526% |
Hogy Medical Co.,Ltd. | 10.77 Billion JPY | 45.453% |
Kawamoto Corporation | 944.44 Million JPY | -522.374% |
Terumo Corporation | 219.66 Billion JPY | 97.324% |
KAINOS Laboratories, Inc. | 1.05 Billion JPY | -456.745% |
JAPAN EYEWEAR HOLDINGS CO LTD | 5.18 Billion JPY | -13.409% |
Sysmex Corporation | 115.67 Billion JPY | 94.918% |
JMS Co.,Ltd. | 3.44 Billion JPY | -70.575% |
Nakanishi Inc. | 32.3 Billion JPY | 81.802% |
Mani, Inc. | 10.69 Billion JPY | 45.06% |
Olympus Corporation | 180.16 Billion JPY | 96.737% |
HOYA Corporation | 260.44 Billion JPY | 97.743% |
SEED Co.,Ltd. | 4.88 Billion JPY | -20.437% |
Asahi Intecc Co., Ltd. | 31.85 Billion JPY | 81.548% |
Medikit Co.,Ltd. | 6.31 Billion JPY | 6.991% |
Daiken Medical Co., Ltd. | 1.65 Billion JPY | -254.645% |
Menicon Co., Ltd. | 16.9 Billion JPY | 65.219% |
Sincere Co., LTD. | 391 Million JPY | -1403.325% |
Platz Co., Ltd. | 267.15 Million JPY | -2100.246% |
Paramount Bed Holdings Co., Ltd. | 23.4 Billion JPY | 74.89% |
Shigematsu Works Co., Ltd. | 1.38 Billion JPY | -324.329% |
Nipro Corporation | 81.2 Billion JPY | 92.762% |
ASO International, Inc. | 602.47 Million JPY | -875.644% |